In the pharmaceutical industry, granulation refers to the process of mixing a powder blend (typically consisting of APIs and excipients) and compressing it using dry methods or with a binder solution, known as dry granulation and wet granulation, respectively. In addition to these common granulation processes, with the continuous expansion of excipient varieties, direct compression/direct filling processes have also gained prominence.
Direct Compression/Direct Filling: Direct compression into tablets or direct filling into capsules involves only two main steps. It refers to the process where the API is uniformly mixed with suitable excipients (such as fillers, disintegrants, and lubricants) and then directly compressed into tablets or filled into capsules.
Some companies have begun using direct powder compression technology for product development, but challenges during industrialization have hindered large-scale production. The main reasons for this phenomenon include a lack of sufficient understanding and awareness of the principles and complexities of direct compression technology, the inability to establish internal control parameters required for the powder state of APIs and excipients, and the inability to effectively conduct in-depth research on the properties of APIs, especially for high-dose drugs. Powder technology affects direct powder compression through the powder state, mainly in four aspects:
1. Compressibility
Batch-to-batch variations in powder bulk properties must be avoided, as they can lead to a significant decline in tablet quality. Most APIs inherently lack good compressibility; therefore, the dilution potential of the filler-binder system must be carefully considered. Firstly, formulations designed for direct compression should be capable of producing tablets with adequate hardness under normal compression forces. For low-dose tablets, due to the low drug content, direct compression generally yields good results, and most excipients for such formulations can be used as needed. Emphasis must be placed on the uniformity of drug distribution and the homogeneity of the active substance. When the proportion of the drug in the tablet is high, the properties of the active substance, as well as the type and use of excipient fillers, require targeted evaluation and control. For active substances, studying the impact of particle size and crystal form on compressibility is crucial.
2. Flowability
Powder flowability is a critical cohesion factor in the compression process, directly affecting the consistency of die filling. Furthermore, flowability plays a significant role in material storage, transport, and mixing. During product manufacturing, powder flowability directly impacts product quality attributes such as weight uniformity, content uniformity, manufacturing methods, material utilization, and production cycle time (e.g., mixing time, compression speed). Powder flow must be sufficient to ensure the material can smoothly reach specific parts of the equipment under ideal conditions throughout the entire tablet manufacturing process, including storage, transport, mixing, and feeding. Generally, the inherently smaller particle size in direct compression leads to more pronounced flow issues compared to wet granulation, imposing higher demands on the production capacity and speed of the tablet press.
3. Content Uniformity
Due to compatibility issues, direct compression blends are prone to segregation and stratification. Additionally, a reduction in the moisture content of the blend can lead to electrostatic charge build-up and particle agglomeration or dispersion. Furthermore, differences in particle size and density between APIs and excipients can also cause stratification and segregation, particularly in the hopper and feed frame of the tablet press. Ideal excipients must have a specific particle size distribution within a narrow range comparable to that of the API, and should contain a certain amount of fine particles to fill the voids between larger active particles or fillers. Moreover, the mixing sequence of solid raw materials and excipients can also contribute to stratification issues to some extent.
4. Lubricant Sensitivity
Regarding lubricant sensitivity, powder blends are more complex than granulated mixtures. During actual tableting, a certain amount of lubricant (such as talc, magnesium stearate) is typically added to the blend to ensure good flowability of the powder or granules for the compression process. In practice, it is necessary to thoroughly pre-mix the other materials before adding and mixing with the lubricant. Lubricants should not be mixed with the direct compression powder blend using high-speed shearing equipment. Furthermore, the original state (e.g., particle size, morphology) of the lubricant particles must be strictly controlled.
The direct compression process is most heavily dependent on the properties of the API, particularly its powder characteristics. If properties such as particle size, morphology, and density of the API vary between batches, it can affect the uniformity of the powder blend, potentially leading to content and content uniformity issues in the final product. If necessary, specifications for the particle size and particle size distribution of the API should be established to ensure consistency of the manufactured product. Of course, if other properties of the API, such as morphology, impact product quality (e.g., intermediate flowability, blend uniformity), they also need to be characterized and controlled. In some cases, the particle size, morphology, density, and other properties of excipients may also require further restrictions, depending on the specific formulation.